Pablo A Silveira

Pablo A Silveira

UNVERIFIED PROFILE

Are you Pablo A Silveira?   Register this Author

Register author
Pablo A Silveira

Pablo A Silveira

Publications by authors named "Pablo A Silveira"

Are you Pablo A Silveira?   Register this Author

36Publications

484Reads

41Profile Views

Is Hematopoietic Stem Cell Transplantation Required to Unleash the Full Potential of Immunotherapy in Acute Myeloid Leukemia?

J Clin Med 2020 Feb 18;9(2). Epub 2020 Feb 18.

Dendritic Cell Research, ANZAC Research Institute, Concord 2139, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm9020554DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073661PMC
February 2020

CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential.

Front Immunol 2019 7;10:1312. Epub 2019 Jun 7.

Dendritic Cell Research, ANZAC Research Institute, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.01312DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568190PMC
June 2019

The cell surface phenotype of human dendritic cells.

Semin Cell Dev Biol 2019 02 27;86:3-14. Epub 2018 Mar 27.

Dendritic Cell Research, ANZAC Research Institute, Concord, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcdb.2018.02.013DOI Listing
February 2019

Disruption of Serinc1, which facilitates serine-derived lipid synthesis, fails to alter macrophage function, lymphocyte proliferation or autoimmune disease susceptibility.

Mol Immunol 2017 02 19;82:19-33. Epub 2016 Dec 19.

St Vincent's Institute, Fitzroy, Victoria 3065, Australia; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria 3065, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2016.12.007DOI Listing
February 2017

Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell Migration.

J Immunol 2016 08 17;197(3):885-98. Epub 2016 Jun 17.

Dendritic Cell Research, ANZAC Research Institute, Sydney, New South Wales 2139, Australia; Sydney Medical School, University of Sydney, Sydney, New South Wales 2006, Australia; Department of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales 2050, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1600259DOI Listing
August 2016

CMRF-56(+) blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses.

Oncoimmunology 2016 Jun 5;5(6):e1168555. Epub 2016 May 5.

ANZAC Research Institute, Concord, NSW, Australia; Sydney Medical School, University of Sydney, Camperdown, NSW, Australia; Department of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Haematology, Concord Repatriation General Hospital, Concord, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1168555DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938320PMC
June 2016

A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset.

Immunol Cell Biol 2016 05 21;94(5):447-57. Epub 2016 Jan 21.

Dendritic Cell Research, ANZAC Research Institute, Concord Repatriation General Hospital, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/icb.2015.116DOI Listing
May 2016

Sleeping Beauty Transposon Mutagenesis as a Tool for Gene Discovery in the NOD Mouse Model of Type 1 Diabetes.

G3 (Bethesda) 2015 Oct 4;5(12):2903-11. Epub 2015 Oct 4.

Immunology and Diabetes Unit, St. Vincent's Institute, Fitzroy, Victoria 3065, Australia Department of Medicine, University of Melbourne, Parkville, Victoria 3010, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1534/g3.115.021709DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683661PMC
October 2015

The CD19 signalling molecule is elevated in NOD mice and controls type 1 diabetes development.

Diabetologia 2013 Dec 8;56(12):2659-68. Epub 2013 Sep 8.

Department of Immunology, Monash University, AMREP building, 89 Commercial Road, Melbourne, VIC, 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-013-3038-2DOI Listing
December 2013

Intrinsic molecular factors cause aberrant expansion of the splenic marginal zone B cell population in nonobese diabetic mice.

J Immunol 2013 Jul 5;191(1):97-109. Epub 2013 Jun 5.

Garvan Institute of Medical Research, Immunology Program, Darlinghurst, New South Wales 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1203252DOI Listing
July 2013

B cell-directed therapies in type 1 diabetes.

Trends Immunol 2011 Jun 29;32(6):287-94. Epub 2011 Apr 29.

Immunology Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.it.2011.03.006DOI Listing
June 2011

A subset of interleukin-21+ chemokine receptor CCR9+ T helper cells target accessory organs of the digestive system in autoimmunity.

Immunity 2011 Apr;34(4):602-15

Department of Immunology, The Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2011.01.021DOI Listing
April 2011

Enhanced responsiveness to T-cell help causes loss of B-lymphocyte tolerance to a β-cell neo-self-antigen in type 1 diabetes prone NOD mice.

Eur J Immunol 2010 Dec 11;40(12):3413-25. Epub 2010 Nov 11.

Immunology Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201040817DOI Listing
December 2010

B-cell tolerance: mechanisms and implications.

Curr Opin Immunol 2010 Oct 9;22(5):566-74. Epub 2010 Sep 9.

Immunology Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2010.08.001DOI Listing
October 2010

Emerging roles for B lymphocytes in Type 1 diabetes.

Expert Rev Clin Immunol 2009 May;5(3):311-24

Immunology Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/eci.09.4DOI Listing
May 2009

Interactions between B-lymphocytes and type 1 NKT cells in autoimmune diabetes.

J Immunotoxicol 2008 Apr;5(2):249-57

Comparative Genomics Centre, James Cook University, Townsville, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15476910802131543DOI Listing
April 2008

Subcongenic analysis of genetic basis for impaired development of invariant NKT cells in NOD mice.

Immunogenetics 2007 Sep 10;59(9):705-12. Epub 2007 Jul 10.

The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00251-007-0236
Web Search
http://link.springer.com/10.1007/s00251-007-0236-4
Publisher Site
http://dx.doi.org/10.1007/s00251-007-0236-4DOI Listing
September 2007

B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling.

Curr Opin Immunol 2007 Jun 12;19(3):327-36. Epub 2007 Apr 12.

The Autoimmunity Research Unit, The Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095279150700060
Publisher Site
http://dx.doi.org/10.1016/j.coi.2007.04.008DOI Listing
June 2007

Invasion of the killer B's in type 1 diabetes.

Front Biosci 2007 Jan 1;12:2183-93. Epub 2007 Jan 1.

Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/2221DOI Listing
January 2007

B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes.

Trends Endocrinol Metab 2006 May-Jun;17(4):128-35. Epub 2006 Apr 3.

Immunology and Inflammation Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tem.2006.03.006DOI Listing
July 2006

Genetic control of susceptibility to autoimmune gastritis.

Int Rev Immunol 2005 Jan-Apr;24(1-2):55-62

Comparative Genomics Centre, James Cook University, Townsville, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08830180590884404DOI Listing
May 2005

The role of B lymphocytes as key antigen-presenting cells in the development of T cell-mediated autoimmune type 1 diabetes.

Curr Dir Autoimmun 2003 ;6:212-27

Jackson Laboratory, Bar Harbor, Me., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000066863DOI Listing
May 2003

Immunopathogenesis, loss of T cell tolerance and genetics of autoimmune gastritis.

Autoimmun Rev 2002 Oct;1(5):290-7

The Russell Grimwade School of Biochemistry and Molecular Biology, The University of Melbourne, Parkville, Victoria 3010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1568-9972(02)00066-6DOI Listing
October 2002